Scorpius Biomanufacturing

Activities: Manufacturing

Scorpius BioManufacturing is a boutique biologics CDMO providing cGMP manufacturing, bioanalytical, and process development services for protein and cell therapy modalities.

Visit website

Profile

Our facility in San Antonio, Texas specializes in working with start-ups, emerging biotechs, and academic researchers. Scorpius was founded by a serial biotech entrepreneur determined to make small-volume programs a big priority. Clients benefit from decades of expertise taking large molecule drugs to market and can rely on Scorpius to offer: Quality, Speed, Flexibility, & Responsiveness.

Our capabilities include:

  • Up to 500-L scale for mammalian-based products
  • Up to 200-L scale for microbial-based products
  • ~8,600 sq. ft. of cGMP cleanroom manufacturing space
  • Dedicated cGMP cleanrooms for cell therapy programs
  • On-site analytical development and QC support
  • Process development services

Company Address:

  • 1305 East Houston Street
  • San Antonio, TX 78205, USA
  • Tel: 726-201-5050
  • Email: hello@scorpiusbiologics.com
  • Web: www.scorpiusbiologics.com

Social media

LinkedIn

 

Trending Articles

  1. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  2. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  3. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  5. Steritas and argenx join forces to advance steroid-sparing therapeutic development With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid...

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Manufacturing

Process development and clinical manufacturing

Process development & cGMP contract manufacturing for biologics and cell therapies
Hi Tech Manufacturing

Mammalian biomanufacturing

Delivering consistent and scalable mammalian-derived products, Scorpius uses its American facilities to advance your drug from R&D to the clinic and beyond
Hi Tech Manufacturing

Microbial biomanufacturing

Scorpius’ team has extensive experience in E. coli microbial biomanufacturing, including hard-to-work-with inclusion bodies
Manufacturing

Scorpius appoints Gary Welch as Interim President

Gary will lead Scorpius through its next phase of growth
Subscribe now